Scoparone ameliorated hepatic inflammation of mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages (42). The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatohepatitis.